The treatment of the chronic cardiac failure in patients with type 2 diabetes mellitus in clinical practice
https://doi.org/10.20538/1682-0363-2011-4-119-122
Abstract
Ethnofactors of chronic cardiac failure (CCF) include type 2 diabetes (D-2). The treatment of patients with diabetes and chronic cardiac failure is very problematic. The aim is to reveal the CCF prevalence rate among D-2 patients in a representative sample of respondents in Orenburg and to assess their treatment. Two groups of D-2 patients were analyzed: the first group consisted of unorganized urban population patients, and the second group consisted of hospital patients. The CCF prevalence rate in patients of the second group (78%) was quite comparable with that in the first group (82%). The analysis of efficiency of CCF treatment in the representative sample has shown that drug treatment was not sufficient from the cardiologist’s point of view. CCF complicates D-2 in most patients. The current therapy aimed at the correction of cardiovascular disorders in patients with diabetes and cardiac failure calls for optimization in accordance with national recommendations.
About the Author
T. Yu. Lityaeva
Оренбургская государственная медицинская академия
Russian Federation
Russian Federation
References
1. Атрощенко Е.С. Сердечная недостаточность у больных сахарным диабетом 2 типа: проблемы и решения//Сердечная недостаточность. 2008. № 9 (6). С. 300-303.
2. Джанашия П.Х., Мирина Е.Ю. Нарушения липидного обмена при сахарном диабете 2-го типа и варианты его коррекции//РМЖ. 2008. № 16 (11). С. 1561-1566.
3. Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (второй пересмотр)//Сердечная недостаточность. 2007. № 8 (2). С. 1-31.
4. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр)//Сердечная недостаточность. 2010. № 11 (1). С. 3-62.
5. Auni G., Seppo L., Japani R. et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects//Diabetes Care. 2008. № 31 (4). С. 714-719.
6. Bauters C., Lamblin N., Fadden E.R. et al. Influence of diabetes mellitus in heart failure risk an outcome//Cardiovasc. Diabetol. 2003. V. 2. № 1.
7. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators // Lancet. 2000. № 355. С. 253-259.
8. Enright P.L., Sherill D.L. ATS Statement: Guidelines for the six-minute walk test//Am. J. Resp. Crit. Care Med. 1998. № 158 (5). С. 1384-1387.
9. Nichols G.A., Hillier T.A., J.R.Erbey et al. Congestive Heart Failure in type 2 diabetes. Prevalence, incidence, and risk factors. http://care.diabetesjournals.org.
Review
For citations:
Lityaeva T.Yu. The treatment of the chronic cardiac failure in patients with type 2 diabetes mellitus in clinical practice. Bulletin of Siberian Medicine. 2011;10(4):119-122. (In Russ.) https://doi.org/10.20538/1682-0363-2011-4-119-122
Views:
1466
Email this article 